NuGen Medical Devices Inc.

PNK:NGMDF

$0.06708 USD

$0.0 (-1.32%)

Volume
29K
Average Volume
7.7K
Market Capitalization
$13.41M
P/E Ratio
-2.66
Dividend Yield
0.00%
Price Target
$
Year High
$0.14
Year Low
$0.05
Payout Ratio
$0.00
Current Ratio
$0.42

Industry, Sector & symbol

Stock Exchange Other OTC
CEO Mr. Ian Heynen
Industry Medical - Devices
Sector Healthcare
Current Symbol NGMDF
CUSIP None
CIK None
Web https://www.nugenmd.com
Phone 833 285 2666
Currency USD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio -2.21
Payout Ratio 0.00
Current Ratio 0.42
Quick Ratio 0.17
Cash Ratio 0.08

Sales & Book Value

Annual Sales $331.4K
Price / Sales 54.13
Cash Flow -0.02
Price / Cash Flow -5.79
Price / Book -5.44

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0558
Trailing P/E Ratio -2.66
PEG Ratio -0.13
P/E Growth -0.13
Net Income $-9.36M
Net Margin -2201.33%
Pretax Margin -2193.78%
Return on Equity 343.11%
Return on Assets -122.89%

Financials Score

AltmanZ Score -9.78
Piotroski Score 3.00
Working Capital -1.29M
Total Assets 6.21M
Ebit -5.95M
Market Cap 13.41M
Total Liabilities 9.94M

Poll Results

About NuGen Medical Devices Inc. (PNK:NGMDF) Stock

NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventional/pediatric vaccines. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada. ...

NuGen Announces Canada-Wide Launch of InsuJet

2024-11-22 17:15:00

3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across Canada Toronto, Ontario--(Newsfile Corp. - November 22, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the national launch of InsuJet™ in Canada. The launch began on November 15, in conjunction with the commemoration of the World Diabetes Day, where InsuJet™ was celebrated and recognized at a special event held at Banting House in London, Ontario - the birthplace of Insulin.

NuGen Announces Results of Special Meeting and Appointment of New Directors

2024-11-14 17:15:00

Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that its shareholders have approved Sol-Millennium Medical HK Limited ("Sol-M") and Nature Health Development (Hong Kong) Co. Limited ("Nature Health") as new Control Persons (as defined in the policies of the TSX Venture Exchange) of the Company. On September 20, 2024, Sol-M and Nature Health acquired an aggregate of C$10 million principal amount secured convertible debentures (the "Convertible Debentures") of the Company.

NuGen Announces Strategic Partnership with EziAutoJector Limited

2024-10-25 17:15:00

5,000 InsuJet devices to be delivered to the UK Toronto, Ontario--(Newsfile Corp. - October 25, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce a strategic partnership with EziAutoJector® Limited ("EziAutoJector"), a company domiciled in Jersey, United Kingdom, for the delivery of U-100 insulin to individuals with diabetes and subcutaneous biosimilar products using NuGen's InsuJetTM device and consumables. U-100 insulin is the standard and most used strength today.

NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures

2024-09-20 17:15:00

Toronto, Ontario--(Newsfile Corp. - September 20, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, further to its press release dated August 15, 2024, Sol-Millennium Medical HK Limited ("Sol-M") and Nature Health Development (Hong Kong) Co. Limited ("Nature Health") have completed their strategic investment in NuGen through the acquisition of an aggregate C$10,000,000 principal amount secured convertible debentures (the "Convertible Debentures") in the Company's non-brokered private placement of Convertible Debentures (the "Offering"). The Company intends to use the proceeds from the Offering for working capital purposes, expansion of production and fulfillment of increasing sale purchase orders globally.

NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement

2024-08-29 17:15:00

Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of Q2 2024 Financial Results and is pleased to provide updates on commercial progress and its proposed private placement of up to $10 million secured convertible debentures (the "Offering"). Q2 Financial Statements Reflect Continued Commercial Ramp-Up Financial results for the Quarter ended June 30, 2024 were in line with management expectations.

Frequently Asked Questions

What is the current NuGen Medical Devices Inc. (NGMDF) stock price?

NuGen Medical Devices Inc.(PNK:NGMDF) stock price is $0.06708 in the last trading session. During the trading session, NGMDF stock reached the peak price of $0.1439 while $0.05 was the lowest point it dropped to. The percentage change in NGMDF stock occurred in the recent session was --1.32% while the dollar amount for the price change in NGMDF stock was -$-0.0.

NGMDF's industry and sector of operation?

The PNK listed NGMDF is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of NGMDF?

Ms. Elisha Dillon | Head of Global Sales & Strategic Partnerships
Mr. Nicky Canton | Executive Vice President & Chief Operating Officer
Ms. Karen Dunlap | Interim Chief Customer Officer & Director
Mr. Lin Liang | Executive Chairman
Ms. Veronique Laberge B.A., CPA | Chief Financial Officer & Secretary

How many employees does NGMDF have?

Number of NGMDF employees currently stands at None. NGMDF operates from 18 King Street East, Toronto, ON M5C 1C4, CA.

Link for NGMDF official website?

Official Website of NGMDF is: https://www.nugenmd.com

How do I contact NGMDF?

NGMDF could be contacted at phone #833 285 2666 and can also be accessed through its website. NGMDF operates from 18 King Street East, Toronto, ON M5C 1C4, CA.

How many shares of NGMDF are traded daily?

The average number of NGMDF shares traded daily for last 3 months was 7.7K.

What is the market cap of NGMDF currently?

The market value of NGMDF currently stands at $13.41M with its latest stock price at $0.06708